BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pogatzki-zahn E, Kranke P, Winner J, Weyland W, Reich A, Vigelius-rauch U, Paland M, Löhr T, Eberhart L. Real-world use of the sufentanil sublingual tablet system for patient-controlled management of acute postoperative pain: a prospective noninterventional study. Current Medical Research and Opinion 2020;36:277-84. [DOI: 10.1080/03007995.2019.1681133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Coccolini F, Corradi F, Sartelli M, Coimbra R, Kryvoruchko IA, Leppaniemi A, Doklestic K, Bignami E, Biancofiore G, Bala M, Marco C, Damaskos D, Biffl WL, Fugazzola P, Santonastaso D, Agnoletti V, Sbarbaro C, Nacoti M, Hardcastle TC, Mariani D, De Simone B, Tolonen M, Ball C, Podda M, Di Carlo I, Di Saverio S, Navsaria P, Bonavina L, Abu-Zidan F, Soreide K, Fraga GP, Carvalho VH, Batista SF, Hecker A, Cucchetti A, Ercolani G, Tartaglia D, Galante JM, Wani I, Kurihara H, Tan E, Litvin A, Melotti RM, Sganga G, Zoro T, Isirdi A, De'Angelis N, Weber DG, Hodonou AM, tenBroek R, Parini D, Khan J, Sbrana G, Coniglio C, Giarratano A, Gratarola A, Zaghi C, Romeo O, Kelly M, Forfori F, Chiarugi M, Moore EE, Catena F, Malbrain MLNG. Postoperative pain management in non-traumatic emergency general surgery: WSES-GAIS-SIAARTI-AAST guidelines. World J Emerg Surg 2022;17:50. [PMID: 36131311 DOI: 10.1186/s13017-022-00455-7] [Reference Citation Analysis]
2 Ji K, Gong X, Luan T, Gao X, Zang B. Pain management of nalbuphine and sufentanil in patients admitted intensive care unit of different ages. BMC Emerg Med 2022;22. [DOI: 10.1186/s12873-022-00592-x] [Reference Citation Analysis]
3 Koushik SS, Schwartz RH, Cherkalin D, Sankar V, Shaparin N, Viswanath O. A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures. Curr Pain Headache Rep. [DOI: 10.1007/s11916-022-01014-0] [Reference Citation Analysis]
4 Amson H, Lasselin P, Naegels B, Pardey Bracho GF, Aubrun F, Dziadzko M. Usability evaluation of sufentanil sublingual tablet analgesia in patients following Enhanced Recovery After Surgery. J Comp Eff Res 2021;10:743-50. [PMID: 33880939 DOI: 10.2217/cer-2020-0239] [Reference Citation Analysis]
5 Thangaraju P, Varthya SB, Venkatesan S, Tamilselvan T, Singh S. Efficacy and safety of sufentanil sublingual tablet system in postoperative pain management: a systematic review and meta-analysis. BMJ Support Palliat Care 2021:bmjspcare-2020-002693. [PMID: 33653734 DOI: 10.1136/bmjspcare-2020-002693] [Reference Citation Analysis]
6 Emons MI, Maring M, Stamer UM, Pogatzki-Zahn E, Petzke F, Erlenwein J. [Safety and monitoring of patient-controlled intravenous analgesia : Clinical practice in German hospitals]. Anaesthesist 2021;70:476-85. [PMID: 33373025 DOI: 10.1007/s00101-020-00907-2] [Reference Citation Analysis]
7 Scardino M, Tartarelli A, Coluzzi F, Corcione A, Lorini FL, Torrano V, Martorano PP, Quaini S. Sublingual sufentanil tablet system for the management of acute postoperative pain in a hospital setting: an observational study. Minerva Anestesiol 2021;87:156-64. [PMID: 32959632 DOI: 10.23736/S0375-9393.20.14592-9] [Reference Citation Analysis]